CHINARES PHARMA(03320): China Resources Double-Crane Pharmaceutical net profit in the first quarter was 501 million yuan, a decrease of 4.085% year-on-year.
China Resources Pharmaceutical (03320) announced that its subsidiary, China Resources Shuanghe Pharmaceutical Co., Ltd. (CR Shuanghe), achieved total operating income of 2.8066 billion yuan for the three months ending on March 31, 2026, a year-on-year decrease of 8.8%. The net profit was 501 million yuan, a year-on-year decrease of 4.085%.
CHINARES PHARMA (03320) announced that its subsidiary, China Resources Double-Crane Pharmaceutical Co., Ltd., achieved total operating revenue of 2.8066 billion yuan in the three months ending March 31, 2026, a decrease of 8.8% compared to the same period last year. The net profit was 501 million yuan, a decrease of 4.085% year-on-year.
Related Articles
MILLIONHOPE IND (01897) cancelled 328,000 shares repurchased on April 24th.
On April 24th, KEEP (03650) spent 880,400 Hong Kong dollars repurchasing 300,000 shares.
FSM Holdings (01721)'s sales revenue from its manufacturing business in the first quarter decreased by approximately 52% to 59% year-on-year.
MILLIONHOPE IND (01897) cancelled 328,000 shares repurchased on April 24th.
On April 24th, KEEP (03650) spent 880,400 Hong Kong dollars repurchasing 300,000 shares.
FSM Holdings (01721)'s sales revenue from its manufacturing business in the first quarter decreased by approximately 52% to 59% year-on-year.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
